Healthcare -
Biotechnology - NASDAQ - US
$ 8.885
-1.39 %
$ 1.42 B
Market Cap
-4.08
P/E
NVAX - COST OF REVENUE
Cost of Revenue NVAX - Novavax, Inc.
344 M
LAST VALUE
421.07%
2 YEAR CAGR
0.00%
5 YEAR CAGR
45.25%
10 YEAR CAGR